ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions

BACKGROUND: Expansion of type 2 innate lymphoid cells (ILC2s) in hypercholesterolaemic mice protects against atherosclerosis while different ILC2 subsets have been described (natural, inflammatory) based on their suppression of tumorigenicity 2 (ST2) and killer-cell lectin like receptor G1 (KLRG1) e...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Immunol
Egile Nagusiak: Mantani, Polyxeni T., Dunér, Pontus, Ljungcrantz, Irena, Nilsson, Jan, Björkbacka, Harry, Fredrikson, Gunilla Nordin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2019
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6905041/
https://ncbi.nlm.nih.gov/pubmed/31823769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12865-019-0330-z
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak